Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Womb (uterine or endometrial) cancer
Closed
Phase 3
This trial is looking at a new drug called AEZS 108 to treat womb (endometrial) cancer.
If womb cancer has spread to other parts of the body, or has come back after it was first treated, it is called advanced womb cancer. Doctors can use treatments such as chemotherapy for advanced womb cancer. One chemotherapy drug they use is called doxorubicin.
AEZS 108 has 2 parts. One part is doxorubicin. The other is a type of . The hormone helps doxorubicin attach to the cancer cells using certain hormone receptors.
The main aim of this trial is to compare AEZS 108 with doxorubicin to find out which helps women with advanced womb cancer live longer.
Recruitment start: 26 July 2013
Recruitment end: 29 June 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Hani Gabra
Aeterna Zentaris Inc
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 03 Aug 2015
CRUK internal database number: 11516
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
